关键词：生物医药；世界趋势

查看摘要 索取原文[1页]

关键词：思瑞康缓释片；获批上市

查看摘要 索取原文[1页]

The healthcare system in Australia is quite a robust model which lays focus on health as well as social well-being. Healthcare in the country is provided majorly by the public sector, followed by the private sector.

关键词：澳洲；医疗系统；注重健康；社会福祉

查看摘要 索取原文[40页]

关键词：生物仿制药；井喷态势；审批

查看摘要 索取原文[1页]

关键词：居民消费；价格变动；医药行业；排名

查看摘要 索取原文[1页]

2013年1-10月，医药行业运行呈现以下特点：一是受GMP稳步推进、GSP实施以及节能减排力度加大等因素影响，投资增速保持在30%以上，但增长势头有所放缓；二是随着“稳增长”政策的出台，增加值增长率和中西药品零售额增速双手止降转升；三是出口额增速低位恢复，进口额进入相对平稳的增长轨道；四是随着药品降价政策的影响逐渐消融，价格总体稳中略升；五是受医保支出和投资收益增速放缓影响，医药行业收入、利润、主营业务利润增速均有所回落。

关键词：医药；运行；投资；生产；产量；化学药品原药；中成药；销量

查看摘要 索取原文[17页]

The Global Electrosurgical Devices market is one of the major markets in the Global Surgical Equipment market and is witnessing continuous developments and innovations. The Americas generates the highest revenue in the Global Electrosurgical Devices market and is followed by the EMEA region. There is a vast opportunity for the market to grow significantly in certain countries in the APAC region such as Japan, India, and China. Moreover, the market in developing countries is expected to grow faster than in other geographies, which may lead to an increase in sales of new surgical products. It is estimated that the Global Electrosurgical Devices market will grow at a CAGR of 5.45 percent during the forecast period.

关键词：医疗器械；外科设备；生物组织；高频电力系统；手术器械；电外科器械

查看摘要 索取原文[57页]

Packaging of products is a process of enclosing or protecting products for the purpose of their distribution, storage, sale, and use. It is useful for advertising a product, for protecting against damage during transportation, for persuading any possible buyer as well as to provide the product with an authentic identity. Healthcare products such as pharmaceuticals and medical devices require packaging so they can be safely transported, to maintain sterility, and to prevent breakage or spillage and contamination. Raw materials used for packaging healthcare products include plastic, glass, metal, and paper-based materials.The increasing aging population is leading to a growing demand for pharmaceuticals and medical devices. Hence, the Global Healthcare Packaging market is growing at a steady rate. The Americas dominated the market in 2012, which was followed by the EMEA region and the APAC region. The US, which accounted for the world's highest per capita healthcare expenditure, was the leading revenue contributor in the Healthcare Packaging market in the Americas in 2012. The market is expected to grow at a CAGR of 7.0 percent during the period 2012-2016.

关键词：产品包装；保健产品；药品；医疗器械

查看摘要 索取原文[54页]

Biophotonics refers to the science of generating and utilizing photons to image and identify biological molecules. This area of scientific research uses light and other forms of radiant energy to identify the functioning of inner cells and tissues in living organisms. The major applications of biophotonics include medical imaging and in vitro diagnostics. Biophotonics is extensively used in applications of oncology, dermatology, ophthalmology, surgery, and cardiology.The Global Biophotonics market is expected to grow at a steady pace during the period 2012-2016. The market was dominated by the Americas in 2012, followed by the EMEA and APAC regions. Currently, a major part of the market growth is derived from the Medical Diagnostics segment. Other segments such as Medical Therapeutics, Non-Medical Applications, and Tests and Components are expected to make significant contributions to the revenue of the overall market in the next few years. The Global Biophotonics market will witness an increase in competition due to low entry barriers. The Global Biophotonics market is expected to post a CAGR of 10.03 percent during the forecast period.

关键词：生物光子学；光子图像；生物分子；辐射能量；细胞和组织

查看摘要 索取原文[75页]

The emerging market for pharmaceutical products is termed as pharmerging. The Global Pharmaceutical market is witnessing a paradigm shift in the marketing of pharmaceutical products from the saturated developed regions to the developing regions, owing to an increased accessibility toward quality healthcare infrastructure supported by funds and investment from the government and private companies. These developing regions are referred to as the Pharmerging markets. Further, big pharmaceutical manufacturers are currently facing a decline in the sales of their products owing to a patent cliff leading to tough competition from generic drug manufacturers. As of 2012, the Pharmerging markets represent 20 percent of the Global Pharmaceutical market and are expected to represent 50 percent of the Global Pharmaceutical market by 2020.

关键词：医药市场；营销模式；医疗保健基础设施；新兴医药市场

查看摘要 索取原文[81页]